- Home
- CMBM vs TENX Comparison
CMBM vs TENX Comparison
Compare CMBM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- TENX
- Stock Information
- Founded
- CMBM 2011
- TENX 1967
- Country
- CMBM United States
- TENX United States
- Employees
- CMBM N/A
- TENX N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- TENX Health Care
- Exchange
- CMBM Nasdaq
- TENX Nasdaq
- Market Cap
- CMBM 25.0M
- TENX 27.3M
- IPO Year
- CMBM 2019
- TENX N/A
- Fundamental
- Price
- CMBM $0.64
- TENX $7.32
- Analyst Decision
- CMBM Buy
- TENX Strong Buy
- Analyst Count
- CMBM 1
- TENX 3
- Target Price
- CMBM $3.00
- TENX $16.67
- AVG Volume (30 Days)
- CMBM 200.8K
- TENX 137.7K
- Earning Date
- CMBM 11-06-2025
- TENX 11-12-2025
- Dividend Yield
- CMBM N/A
- TENX N/A
- EPS Growth
- CMBM N/A
- TENX N/A
- EPS
- CMBM N/A
- TENX N/A
- Revenue
- CMBM $172,215,000.00
- TENX N/A
- Revenue This Year
- CMBM N/A
- TENX N/A
- Revenue Next Year
- CMBM $17.73
- TENX N/A
- P/E Ratio
- CMBM N/A
- TENX N/A
- Revenue Growth
- CMBM N/A
- TENX N/A
- 52 Week Low
- CMBM $0.23
- TENX $4.04
- 52 Week High
- CMBM $1.69
- TENX $8.24
- Technical
- Relative Strength Index (RSI)
- CMBM 39.09
- TENX 57.19
- Support Level
- CMBM $0.75
- TENX $6.10
- Resistance Level
- CMBM $0.87
- TENX $7.70
- Average True Range (ATR)
- CMBM 0.09
- TENX 0.52
- MACD
- CMBM -0.03
- TENX -0.09
- Stochastic Oscillator
- CMBM 11.67
- TENX 56.87
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.